• Business
    InvestorPlace

    Gilead Sciences’ Coronavirus Treatment Has Big-Time Potential

    The coronavirus continues to sweep across the world. It's hitting Europe and the U.S. hard after the outbreak began in China. Despite the hellish reality of Covid-19, we're seeing individual companies step up, like Gilead Sciences (NASDAQ:GILD). As a result, GILD stock is up 16.3% year-to-date and 9% over the past month.Some investors may look at that and say, "so what?"But compare that to the SPDR S&P 500 ETF (NYSEARCA:SPY), which is down 22% and 15.3% in the same time frame and you can understand why Gilead has stood out. It's also why it has the potential to shine even brighter in the coming weeks and months.InvestorPlace - Stock Market News, Stock Advice & Trading Tips Gilead vs. Covid-19The virus is bringing out the best in many American companies. Ford (NYSE:F), General Motors (NYSE:GM) and Tesla (NASDAQ:TSLA) are producing ventilators. Gap (NYSE:GPS), Ralph Lauren (NYSE:RL) and others are producing scrubs, gowns and other supplies. Breweries are making hand sanitizer. We're stepping up. And so is biotech. * 10 Stocks to Buy Whose Companies We Can't Live Without Gilead is working on a Covid-19 treatment with a drug called remdesivir. On March 23, the FDA granted remdesivir "orphan status." That designation would, among other things, give it exclusivity rights. However, just a few days later Gilead filed with the FDA to remove that status. Click to Enlarge Source: Chart courtesy of Statista, Source from WHO The company said it could maintain an "expedited timeline" without the status, and that the designation is meant to apply for infections impacting less than 200,000 Americans. With more than 215,000 confirmed coronavirus cases in the U.S. and growing rapidly, it's clear the number will be far higher.Gilead CEO Daniel O'Day recently said that remdesivir is "a medicine we had been studying for many years as part of our extensive research in antivirals … Multiple studies are ongoing, and we are on track to have initial data in the coming weeks."On April 1, the company initiated two Phase 3 trials for remdesivir for use in patients with moderate to severe Covid-19.This is all moving along very quickly. If Gilead sees promising results, not only is that huge for Gilead but it's huge for the world. We need some sort of positive catalyst here. Not just for the stock market, but for humanity. People are growing tired of being on lockdown orders and anxiety is creeping higher for many out of work.If Gilead's remdesivir works, it could be a game changer. Sizing Up GILD Stock Click to Enlarge Source: Chart courtesy of StockCharts.comA glance at the chart above highlights what life has been like for long-term investors in Gilead. Simply put, the stock has been a painful one to own. Shares embarked on a brutal decline from a high north of $100 in 2015 to a low near $57.50 in 2017. It has since been trying to carve out a bottom.Shares moved slowly but constructively higher in 2019, leading to a breakout in 2020. Of course, that's on the back of the company's remdesivir hopes, putting Gilead in a somewhat binary situation.Binary situations are generally unattractive from an investment perspective, particularly when they center around a treatment being accepted or rejected. As it stands though, investors may be safe buying a pullback into the $65 to $70 area. As long as GILD stays above $65, its technicals are in good shape.On the upside, look for a rally back up to resistance between $77.50 to $80. A breakout over $80 puts the recent highs near $86 on the table.While Gilead shares has been hammered over the years, its fundamentals have deteriorated a bit over that time as well. But -- and this is a big but -- Gilead Sciences is not your typical fly-by-night binary biotech play. It's a low valuation, cash-rich healthcare titan.The company boasts $24.3 billion in cash -- $19.4 billion including its recent acquisition of Forty Seven (NASDAQ:FTSV). Trailing free cash flow is north of $8.3 billion, with revenue and net income of $22.4 billion and $5.4 billion, respectively. Gilead may not be in its prime, but it's a very profitable machine.Investors could do worse than pay 11.3 times this year's earnings for a company like Gilead, with the upside kicker being remdesivir.Matthew McCall left Wall Street to actually help investors -- by getting them into the world's biggest, most revolutionary trends BEFORE anyone else. The power of being "first" gave Matt's readers the chance to bank +2,438% in Stamps.com (STMP), +1,523% in Ulta Beauty (ULTA) and +1,044% in Tesla (TSLA), just to name a few. Click here to see what Matt has up his sleeve now. Matt does not directly own the aforementioned securities. More From InvestorPlace * 25 Stocks You Should Sell Immediately * 1 Under-the-Radar 5G Stock to Buy Now * This Stock Picker's Latest Video Just Went Viral * The 1 Stock All Retirees Must Own The post Gilead Sciencesa€™ Coronavirus Treatment Has Big-Time Potential appeared first on InvestorPlace.

  • Politics
    The Week

    The noble lie about masks and coronavirus should never have been told

    Those of you of a certain age will doubtless remember a time when it was universally acknowledged that wearing masks would not protect you or anyone else from the coronavirus pandemic. By "certain age" here I mean all living Americans born on or before April 1, 2020, which according to my notes is when it became possible to express a contrary position in polite society.This was always nonsense. The White House is now suggesting that all of us should wear masks whenever we leave our houses. We are even stealing vast stockpiles of them from the Germans, who have been wearing them in public for around a month on the rather more numerous occasions when their leaders exempt them from house arrest. People who can't get proper masks (apparently the kind people wear when they spray for bugs) are being encouraged to make their own. If nothing else, this has given tedious DIY addicts something else to be self satisfied about. No one cares how quaint and interesting you think the piece of cloth meant to protect you from a disease is, okay?Whether the journalists and other apparent experts who enthusiastically spread this apparent lie about masks knew it was false is very much an open question. Some of us found it odd that the same people were also saying that masks should be reserved for use by medical professionals. If masks don't do anything, why do doctors and nurses need them? Are they an ornamental part of a dress uniform? The mind reels.Regardless of the personal honesty of those involved in it, this propaganda campaign should never have been conducted in the first place. It is one thing to debate what should be empirical questions, such as the efficacy of wearing protective equipment in an attempt to forestall the spread of viral infections; it is another for people to bang on about whatever the latest current corona wisdom is with the same tedious certainty that not long ago made us a nation of Logan Act scholars and experts on the non-existent criminal law implications of the emoluments clause. These manias do roughly as much for public health as those kids — there was at least one in every first-grade class — who relentlessly ssshh everyone else in line do to improve schoolyard behavior.The 180-degree shift in acceptable public opinion about masks is in line with how the rest of this crisis has unfolded. Masks won't help. Everyone needs a mask. It's not worth shutting down travel to and from China over the virus, and Trump is just being a xenophobe here. Trump should have done more to prevent the virus from coming to these shores. It's less dangerous than the flu; calling it less dangerous than the flu is a right-wing meme, perhaps even (one shudders) "misinformation." Human beings can't even transmit the virus directly to one another; it originated with animals in Chinese open-air "wet" food markets. Talking about the wet markets is racist, except when Dr. Fauci does it.Can we please stop talking this way? As I write this our paper of record is all but publicly rooting for the failure of anti-malarial drugs that appear to have been successful in treating some coronavirus patients. It is not against "science," whatever that may be, for the president or anyone else to observe that certain medicines or treatments have worked. It is not for science, either. It's just a fact that may or may not have limited application depending upon what happens over the next few months. A bit more epistemic humility would be welcome all around.As would more of I will bluntly call adult behavior. We must put an end to the idea that the best way to get through this crisis is to say things we know are not true in the hope of getting people to behave a certain way. This means not saying masks are useless when what you really mean is, "Masks are in short supply, please consider before you start hoarding them whether you really need them at present and if so how many." Ditto the painfully relentless attempts to give young people the impression that they are horribly likely to die from the new virus. Even in Italy, the country with the worst measured fatality rate so far, around 86 percent of all the deceased have been aged 70 or older, and 50 percent were at least 80. We do not need to zero in on statistical anomalies or otherwise engage in scaremongering. It should be enough to say, "Even though you are very unlikely to die from coronavirus, remember that you could contract the disease and spread it to more vulnerable people without even experiencing symptoms, so please don't revel with 5000 strangers at the beach and then run home to give Grandma a hug."This is how grown-ups talk to one another.More stories from theweek.com Social distancing is going to get darker What is 'essential work' in the coronavirus fight? 5 brutally funny cartoons about Trump's TV ratings boast

  • Entertainment
    Deadline

    Rebecca Ramsey Dies: Visual Effects Producer On ‘Watchmen’, ‘Spider-Man 3’ & More Was 53

    Rebecca Ramsey, whose dozens of visual effects credits include Watchmen, The Hunger Games and Harry Potter and the Deathly Hallows, has died. She was 53. Ramsey passed on March 7 from complications related to a fall in her home, according to her longtime friend, Jenny McShane. Ramsey was a producer and EP of VFX, VR/AR/MR, 3D stereo, […]

  • Lifestyle
    GQ

    The Real-Life Diet of the WWE's Edge, An Extremely Cut 46-Year-Old Man

    Nearly a decade after triple-fusion neck surgery, Edge has an entirely new outlook on healthy living.

  • U.S.
    Town and Country Videos

    Two members of the Kennedy family drown after boating in Chesapeake Bay

    Two members of the Kennedy family, Maeve Kennedy Townsend McKean and her 8-year-old son Gideon Joseph Kennedy McKean, have drowned near Annapolis, Md. According to the Washington Post, Maeve's husband, David, confirmed that his wife and son were canoeing on the Chesapeake Bay Thursday and had not been seen since.

  • Politics
    Good Morning America

    George W. Bush in 2005: 'If we wait for a pandemic to appear, it will be too late to prepare'

    In the summer of 2005, President George W. Bush was on vacation at his ranch in Crawford, Texas, when he began flipping through an advanced copy of a new book about the 1918 flu pandemic. "You've got to read this," Fran Townsend remembers the president telling her. Thus was born the nation's most comprehensive pandemic plan -- a playbook that included diagrams for a global early warning system, funding to develop new, rapid vaccine technology, and a robust national stockpile of critical supplies, such as face masks and ventilators, Townsend said.